查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1529852

临床试验生物储存库和檔案解决方案市场规模、份额、趋势分析报告：按服务、产品、阶段、地区和细分市场预测，2024-2030 年

Clinical Trial Biorepository & Archiving Solutions Market Size, Share & Trends Analysis Report By Service (Biorepository Services, Archiving Solution Services), By Product, By Phase, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 192 Pages | 商品交期: 2-10个工作天内

价格

临床试验生物储存库和檔案解决方案市场成长和趋势：

Grand View Research, Inc. 的最新报告显示，到 2030 年，临床试验生物样本库和归檔解决方案的全球市场规模将达到 70 亿美元，预计 2024 年至 2030 年复合年增长率为 8.17%。

这主要是由于生物样本管理在临床试验中的重要性日益增加以及简化资料收集和报告的愿望。此外，精准医学、个人化医学和基因组医学的扩展、研发成本的增加以及透过采用 LIMS（实验室资讯管理系统）等实验室样本管理软体来促进资料收集和报告的努力都是推动行业发展的重要因素。

多个监管机构为生物样本库的运作提供建议并制定最佳实践。国际生物与环境储存库协会正在加强其在全球生物储存程序标准化方面的地位。美国病理学家学会建立了第一个生物样本库认证计划，该计划遵守严格的法规来标准化生物样本库实践。国际标准化组织 (ISO-20387) 发布了有关生物保存能力、公平性和一致操作的生物保存设施标准。

美国FDA制定了良好生产规范（GMP）、良好实验室规范（GLP）、GDP和良好组织规范（GTP），其中包括与药品包装和储存相关的要素。此外，COVID-19 大流行为当地企业创造了一些成长机会。为了巩固在行业中的立足点，主要企业正在采取各种计划和政策，以在全球市场上获得更大的收益占有率。作为重要的一步，主要企业可以与相关第三方供应商建立合作关係。这可以透过适当的沟通和调整临床试验生物检体资料库和归檔解决方案的频率和数量来实现。

临床试验生物储存库和檔案解决方案市场报告亮点：

  • 由于个人化医疗等先进疗法的研究和开发不断增加，并且需要高品质的生物检体资料库实践来进行样本收集、处理、测试和存储，生物检体资料库服务领域将在 2022 年占据行业主导地位。
  • 按阶段来看，预计 III 期细分市场将在 2022 年占据行业主导地位，而 II 期细分市场预计将在 2023 年至 2030 年实现最快的复合年增长率。
  • 2022 年，临床产品领域占据最大份额，因为大多数临床试验方案都严重依赖生物检体分析来满足试验终点。
  • 预计亚太地区在预测期内将实现最快的成长率。临床试验设施从欧洲、北美等西方地区转移到亚太地区的是推动该地区发展的主要因素。

目录

第一章调查方法和范围

第 2 章执行摘要

第 3 章：临床试验生物储存库和檔案解决方案市场的变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 临床试验生物储存库和檔案解决方案市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析
    • COVID-19 影响分析

第 4 章 临床试验生物储存库和存檔解决方案市场：按服务分类的估计和趋势分析

  • 临床试验生物储存库和檔案解决方案市场，按服务：细分仪表板
  • 临床试验生物储存库和檔案解决方案市场（按服务）：变异分析
  • 临床试验生物储存库和檔案解决方案市场（按服务）：市场估计和预测，2018-2030 年

第五章 临床试验生物储存库和檔案解决方案市场：按产品估计和趋势分析

  • 临床试验生物样本库和檔案解决方案市场，按产品：细分仪表板
  • 临床试验生物样本库和檔案解决方案市场，副产品：变异分析
  • 临床试验生物样本库和檔案解决方案市场（按产品类型）：2018-2030 年市场估计和预测

第六章临床试验生物储存库和檔案解决方案市场：按阶段估计和趋势分析

  • 临床试验生物样本库和檔案解决方案市场，按阶段：细分仪表板
  • 临床试验生物样本库和檔案解决方案市场（按阶段）：变异分析
  • 临床试验生物样本库和檔案解决方案市场，按阶段：市场估计和预测，2018-2030

第七章临床试验生物储存库和檔案解决方案市场：区域估计和趋势分析

  • 2023 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 全球区域市场概述
  • 北美洲
    • 2018-2030 年北美市场估计与预测
    • 美国
    • 加拿大
  • 欧洲
    • 2018-2030 年欧洲市场估计与预测
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 2018-2030 年亚太市场估计与预测
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 2018-2030 年拉丁美洲市场估计与预测
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 2018-2030 年中东和非洲市场估计和预测
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争格局

  • 市场参与企业分类
    • 创新者
    • 市场领导者
    • 新兴玩家
    • 2023 年企业市场占有率分析
  • 公司简介
    • Medpace
    • American Type Culture Collection（ATCC）
    • Cell&Co BioServices（Cryoport）
    • Brooks Life Sciences（Azenta, Inc.）
    • Patheon（Thermo Fisher Scientific, Inc.）
    • Precision Medicine Group, LLC.
    • Labcorp Drug Development
    • Q2 Solutions
    • LabConnect
    • Charles River Laboratories
Product Code: GVR-4-68039-532-8

Clinical Trial Biorepository & Archiving Solutions Market Growth & Trends:

The global clinical trial biorepository & archiving solutions market size was valued at USD 7.0 billion in 2030 and is projected to grow at a CAGR of 8.17% from 2024 to 2030, according to a new report by Grand View Research, Inc. This is mainly due to the increasing importance of biological sample management in clinical trials and the desire to streamline data collection and reporting. In addition, the expansion of precision, personalized, and genomic medicine, increased R&D spending and efforts to make data gathering & reporting easier by employing software like the Laboratory Information Management System (LIMS) to manage laboratory samples are all key factors driving the industry growth.

Multiple regulatory agencies advise and develop best practices in biorepository operations. The International Society for Biological and Environmental Repositories has strengthened its position in the standardization of bio-storage procedures on a global level. The College of American Pathologists established the first biorepository accreditation scheme that adheres to stringent regulations to standardize biorepository practices. Biorepository standards for competence, impartiality, and consistent operation for bio storage have been issued by the International Organization for Standardization (ISO-20387).

The U.S. FDA has established Good Manufacturing Practice (GMP), Good Laboratory Practice (GLP), GDP, and Good Tissue Practice (GTP), which contain the elements associated with the packing and storage of drug products. In addition, the COVID-19 pandemic has created several growth opportunities for local companies. To enhance their foothold in the industry, key companies are adopting various plans and policies to gain a more significant revenue share in the global market. The important step key players can incorporate partnering with relevant third-party vendors. It can be achieved through proper communication and adjustments in the frequency and volume of clinical trial biorepository and archiving solutions.

Clinical Trial Biorepository & Archiving Solutions Market Report Highlights:

  • The biorepository services segment dominated the industry in 2022 due to the rise in R&D of advanced therapies, such as personalized medicine, and the requirement of high-quality biorepository practices for the collection, processing, testing, and storage of samples
  • In terms of phase, the phase III segment dominated the industry in 2022 while the phase II segment is estimated to register the fastest CAGR from 2023 to 2030
  • The clinical products segment held the largest share in 2022 as most clinical trial protocols depend largely on the analysis of biological specimens to meet the study endpoints
  • Asia Pacific is anticipated to register the fastest growth rate over the forecast period. The shift of clinical trial sites from Western regions, such as Europe and North America, to Asia Pacific is a major factor driving the region

Table of Contents

Chapter 1. Research Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Service
    • 1.2.2. Product
    • 1.2.3. Phase
  • 1.3. Regional Scope
  • 1.4. Estimates And Forecast Timeline
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information Or Data Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
    • 1.9.2. Parent Market Analysis
  • 1.10. List Of Secondary Sources
  • 1.11. List Of Abbreviations
  • 1.12. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Clinical Trial Biorepository & Archiving Solutions Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Growing number of pharmaceutical and biotechnology companies
      • 3.2.1.2. Growing disease variation and prevalence
      • 3.2.1.3. Increasing R&D investments
      • 3.2.1.4. Growth in the CRO market
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Regulations for new drug development
      • 3.2.2.2. Rising cost of clinical trials
  • 3.3. Clinical Trial Biorepository & Archiving Solutions Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Clinical Trial Biorepository & Archiving Solutions Market: Service Estimates & Trend Analysis

  • 4.1. Clinical Trial Biorepository & Archiving Solutions Market, By Service: Segment Dashboard
  • 4.2. Clinical Trial Biorepository & Archiving Solutions Market, By Service: Movement Analysis
  • 4.3. Clinical Trial Biorepository & Archiving Solutions Market Estimates & Forecasts, By Service, 2018 - 2030
    • 4.3.1. Biorepository Services
      • 4.3.1.1. Biorepository Services Market, 2018 to 2030 (USD Million)
      • 4.3.1.2. Warehousing & storage
      • 4.3.1.2.1. Warehousing & storage Market, 2018 to 2030 (USD Million)
      • 4.3.1.3. Transportation
      • 4.3.1.3.1. Transportation Market, 2018 to 2030 (USD Million)
      • 4.3.1.4. Sample Processing
      • 4.3.1.4.1. Sample Processing Market, 2018 to 2030 (USD Million)
      • 4.3.1.5. Others Biorepository Services
      • 4.3.1.5.1. Others Biorepository Services Market, 2018 to 2030 (USD Million)
    • 4.3.2. Archiving Solution Services
      • 4.3.2.1. Archiving Solution Services Market, 2018 to 2030 (USD Million)
      • 4.3.2.2. Database Indexing and Management
      • 4.3.2.2.1. Database Indexing and Management Market, 2018 to 2030 (USD Million)
      • 4.3.2.3. Scanning & Destruction
      • 4.3.2.3.1. Scanning & Destruction Market, 2018 to 2030 (USD Million)

Chapter 5. Clinical Trial Biorepository & Archiving Solutions Market: Product Estimates & Trend Analysis

  • 5.1. Clinical Trial Biorepository & Archiving Solutions Market, By Product: Segment Dashboard
  • 5.2. Clinical Trial Biorepository & Archiving Solutions Market, By Product: Movement Analysis
  • 5.3. Clinical Trial Biorepository & Archiving Solutions Market Estimates & Forecasts, By Product Type, 2018 - 2030
    • 5.3.1. Preclinical Products
      • 5.3.1.1. Preclinical Products Market, 2018 to 2030 (USD Million)
    • 5.3.2. Clinical Products
      • 5.3.2.1. Clinical Products Market, 2018 to 2030 (USD Million)
      • 5.3.2.2. Human Tissue
      • 5.3.2.2.1. Human Tissue Market, 2018 to 2030 (USD Million)
      • 5.3.2.3. Organs
      • 5.3.2.3.1. Organs Market, 2018 to 2030 (USD Million)
      • 5.3.2.4. Stem Cells
      • 5.3.2.4.1. Stem Cells Market, 2018 to 2030 (USD Million)
      • 5.3.2.5. Other Biospecimens
      • 5.3.2.5.1. Other Biospecimens Market, 2018 to 2030 (USD Million)

Chapter 6. Clinical Trial Biorepository & Archiving Solutions Market: Phase Estimates & Trend Analysis

  • 6.1. Clinical Trial Biorepository & Archiving Solutions Market, By Phase: Segment Dashboard
  • 6.2. Clinical Trial Biorepository & Archiving Solutions Market, By Phase: Movement Analysis
  • 6.3. Clinical Trial Biorepository & Archiving Solutions Market Estimates & Forecasts, By Phase, 2018 - 2030
    • 6.3.1. Preclinical
      • 6.3.1.1. Preclinical Market, 2018 to 2030 (USD Million)
    • 6.3.2. Phase I
      • 6.3.2.1. Phase I Market, 2018 to 2030 (USD Million)
    • 6.3.3. Phase II
      • 6.3.3.1. Phase II Market, 2018 to 2030 (USD Million)
    • 6.3.4. Phase III
      • 6.3.4.1. Phase III Market, 2018 to 2030 (USD Million)
    • 6.3.5. Phase IV
      • 6.3.5.1. Phase IV Market, 2018 to 2030 (USD Million)

Chapter 7. Clinical Trial Biorepository & Archiving Solutions Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2023 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. North America
    • 7.4.1. North America Market Estimates and Forecast, 2018 - 2030 (Revenue, USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Scenario
      • 7.4.2.4. U.S. Market Estimates and Forecasts, 2018 - 2030
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Scenario
      • 7.4.3.4. Canada Market Estimates and Forecasts, 2018 - 2030
  • 7.5. Europe
    • 7.5.1. Europe Market Estimates and Forecast, 2018 - 2030 (Revenue, USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Scenario
      • 7.5.2.4. UK Market Estimates and Forecasts, 2018 - 2030
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Scenario
      • 7.5.3.4. Germany Market Estimates and Forecasts, 2018 - 2030
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Scenario
      • 7.5.4.4. France Market Estimates and Forecasts, 2018 - 2030
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Competitive Scenario
      • 7.5.5.3. Regulatory Scenario
      • 7.5.5.4. Italy Market Estimates and Forecasts, 2018 - 2030
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Competitive Scenario
      • 7.5.6.3. Regulatory Scenario
      • 7.5.6.4. Spain Market Estimates and Forecasts, 2018 - 2030
    • 7.5.7. Denmark
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Scenario
      • 7.5.7.4. Denmark Market Estimates and Forecasts, 2018 - 2030
    • 7.5.8. Sweden
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Competitive Scenario
      • 7.5.8.3. Regulatory Scenario
      • 7.5.8.4. Sweden Market Estimates and Forecasts, 2018 - 2030
    • 7.5.9. Norway
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Competitive Scenario
      • 7.5.9.3. Regulatory Scenario
      • 7.5.9.4. Norway Market Estimates and Forecasts, 2018 - 2030
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Market Estimates and Forecast, 2018 - 2030 (Revenue, USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Scenario
      • 7.6.2.4. Japan Market Estimates and Forecasts, 2018 - 2030
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Scenario
      • 7.6.3.4. China Market Estimates and Forecasts, 2018 - 2030
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Scenario
      • 7.6.4.4. India Market Estimates and Forecasts, 2018 - 2030
    • 7.6.5. South Korea
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Scenario
      • 7.6.5.4. South Korea Market Estimates and Forecasts, 2018 - 2030
    • 7.6.6. Australia
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Competitive Scenario
      • 7.6.6.3. Regulatory Scenario
      • 7.6.6.4. Australia Market Estimates and Forecasts, 2018 - 2030
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Competitive Scenario
      • 7.6.7.3. Regulatory Scenario
      • 7.6.7.4. Thailand Market Estimates and Forecasts, 2018 - 2030
  • 7.7. Latin America
    • 7.7.1. Latin America Market Estimates and Forecast, 2018 - 2030 (Revenue, USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Scenario
      • 7.7.2.4. Brazil Market Estimates and Forecasts, 2018 - 2030
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Scenario
      • 7.7.3.4. Argentina Market Estimates and Forecasts, 2018 - 2030
  • 7.8. MEA
    • 7.8.1. MEA Market Estimates and Forecast, 2018 - 2030 (Revenue, USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Competitive Scenario
      • 7.8.2.3. Regulatory Scenario
      • 7.8.2.4. South Africa Market Estimates and Forecasts, 2018 - 2030
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Competitive Scenario
      • 7.8.3.3. Regulatory Scenario
      • 7.8.3.4. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Competitive Scenario
      • 7.8.4.3. Regulatory Scenario
      • 7.8.4.4. UAE Market Estimates and Forecasts, 2018 - 2030
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Competitive Scenario
      • 7.8.5.3. Regulatory Scenario
      • 7.8.5.4. Kuwait Market Estimates and Forecasts, 2018 - 2030

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
    • 8.1.1. Innovators
    • 8.1.2. Market Leaders
    • 8.1.3. Emerging Players
    • 8.1.4. Company Market Share Analysis, 2023
  • 8.2. Company Profiles
    • 8.2.1. Medpace
      • 8.2.1.1. Company Overview
      • 8.2.1.2. Financial Performance
      • 8.2.1.3. Service Benchmarking
      • 8.2.1.4. Strategic Initiatives
    • 8.2.2. American Type Culture Collection (ATCC)
      • 8.2.2.1. Company Overview
      • 8.2.2.2. Financial Performance
      • 8.2.2.3. Service Benchmarking
      • 8.2.2.4. Strategic Initiatives
    • 8.2.3. Cell&Co BioServices (Cryoport)
      • 8.2.3.1. Company Overview
      • 8.2.3.2. Financial Performance
      • 8.2.3.3. Service Benchmarking
      • 8.2.3.4. Strategic Initiatives
    • 8.2.4. Brooks Life Sciences (Azenta, Inc.)
      • 8.2.4.1. Company Overview
      • 8.2.4.2. Financial Performance
      • 8.2.4.3. Service Benchmarking
      • 8.2.4.4. Strategic Initiatives
    • 8.2.5. Patheon (Thermo Fisher Scientific, Inc.)
      • 8.2.5.1. Company Overview
      • 8.2.5.2. Financial Performance
      • 8.2.5.3. Service Benchmarking
      • 8.2.5.4. Strategic Initiatives
    • 8.2.6. Precision Medicine Group, LLC.
      • 8.2.6.1. Company Overview
      • 8.2.6.2. Financial Performance
      • 8.2.6.3. Service Benchmarking
      • 8.2.6.4. Strategic Initiatives
    • 8.2.7. Labcorp Drug Development
      • 8.2.7.1. Company Overview
      • 8.2.7.2. Financial Performance
      • 8.2.7.3. Service Benchmarking
      • 8.2.7.4. Strategic Initiatives
    • 8.2.8. Q2 Solutions
      • 8.2.8.1. Company Overview
      • 8.2.8.2. Financial Performance
      • 8.2.8.3. Service Benchmarking
      • 8.2.8.4. Strategic Initiatives
    • 8.2.9. LabConnect
      • 8.2.9.1. Company Overview
      • 8.2.9.2. Financial Performance
      • 8.2.9.3. Service Benchmarking
      • 8.2.9.4. Strategic Initiatives
    • 8.2.10. Charles River Laboratories
      • 8.2.10.1. Company Overview
      • 8.2.10.2. Financial Performance
      • 8.2.10.3. Service Benchmarking
      • 8.2.10.4. Strategic Initiatives

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. North America Clinical Trial Biorepository & Archiving Solutions market, by region, 2018 - 2030 (USD Million)
  • Table 4. North America Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 5. North America Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 6. North America Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 7. U.S. Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 8. U.S. Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 9. U.S. Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 10. Canada Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 11. Canada Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 12. Canada Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 13. Europe Clinical Trial Biorepository & Archiving Solutions market, by region, 2018 - 2030 (USD Million)
  • Table 14. Europe Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 15. Europe Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 16. Europe Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 17. UK Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 18. UK Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 19. UK Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 20. Germany Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 21. Germany Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 22. Germany Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 23. France Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 24. France Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 25. France Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 26. Italy Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 27. Italy Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 28. Italy Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 29. Spain Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 30. Spain Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 31. Spain Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 32. Denmark Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 33. Denmark Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 34. Denmark Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 35. Sweden Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 36. Sweden Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 37. Sweden Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 38. Norway Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 39. Norway Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 40. Norway Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 41. Asia Pacific Clinical Trial Biorepository & Archiving Solutions market, by region, 2018 - 2030 (USD Million)
  • Table 42. Asia Pacific Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 43. Asia Pacific Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 44. Asia Pacific Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 45. Japan Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 46. Japan Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 47. Japan Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 48. China Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 49. China Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 50. China Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 51. India Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 52. India Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 53. India Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 54. Australia Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 55. Australia Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 56. Australia Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 57. South Korea Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 58. South Korea Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 59. South Korea Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 60. Thailand Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 61. Thailand Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 62. Thailand Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 63. Latin America Clinical Trial Biorepository & Archiving Solutions market, by region, 2018 - 2030 (USD Million)
  • Table 64. Latin America Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 65. Latin America Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 66. Latin America Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 67. Brazil Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 68. Brazil Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 69. Brazil Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 70. Mexico Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 71. Mexico Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 72. Mexico Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 73. Argentina Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 74. Argentina Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 75. Argentina Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 76. Colombia Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 77. Colombia Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 78. Colombia Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 79. Middle East & Africa Clinical Trial Biorepository & Archiving Solutions market, by region, 2018 - 2030 (USD Million)
  • Table 80. Middle East & Africa Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 81. Middle East & Africa Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 82. Middle East & Africa Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 83. South Africa Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 84. South Africa Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 85. South Africa Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 86. Saudi Arabia Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 87. Saudi Arabia Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 88. Saudi Arabia Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 89. UAE Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 90. UAE Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 91. UAE Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)
  • Table 92. Kuwait Clinical Trial Biorepository & Archiving Solutions market, by service, 2018 - 2030 (USD Million)
  • Table 93. Kuwait Clinical Trial Biorepository & Archiving Solutions market, by product, 2018 - 2030 (USD Million)
  • Table 94. Kuwait Clinical Trial Biorepository & Archiving Solutions market, by phase, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Clinical trial biorepository & archiving solutions market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Market formulation & validation
  • Fig. 7 Commodity flow analysis
  • Fig. 8 Value-chain-based sizing & forecasting
  • Fig. 9 QFD model sizing & forecasting
  • Fig. 10 Bottom-up approach
  • Fig. 11 Market snapshot
  • Fig. 12 Segment snapshot 1
  • Fig. 13 Segment snapshot 2
  • Fig. 14 Competitive landscape snapshot
  • Fig. 15 Parent market outlook, 2023 (USD Billion)
  • Fig. 16 Ancillary market outlook, 2023 (USD Billion)
  • Fig. 17 Clinical trial biorepository & archiving solutions market dynamics
  • Fig. 18 Porter's five forces analysis
  • Fig. 19 PESTEL analysis
  • Fig. 20 Clinical trial biorepository & archiving solutions market: Service outlook and key takeaways
  • Fig. 21 Clinical Trial Biorepository & Archiving Solutions market: Service movement analysis
  • Fig. 22 Biorepository services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Warehousing & storage market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Transportation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Sample processing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Others biorepository services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Archiving solution services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Database indexing & management market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Scanning & destruction market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Clinical Trial Biorepository & Archiving Solutions market: Product outlook and key takeaways
  • Fig. 31 Clinical Trial Biorepository & Archiving Solutions market: Product movement analysis
  • Fig. 32 Preclinical products market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Clinical products market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Human tissue market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Organs market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Stem cells market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Other biospecimens market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Clinical Trial biorepository & archiving solutions market: Phase outlook and key takeaways
  • Fig. 39 Clinical trial biorepository & archiving solutions market: Phase movement analysis
  • Fig. 40 Preclinical market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Phase I market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Phase II market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Phase III market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Phase IV market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 Regional Marketplace: Key Takeaways
  • Fig. 46 North America clinical trial biorepository & archiving solutions market estimates and forecasts, 2018-2030 (USD Million)
  • Fig. 47 Key country dynamics
  • Fig. 48 U.S. clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Key country dynamics
  • Fig. 50 Canada clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Europe clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Key country dynamics
  • Fig. 53 UK clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Key country dynamics
  • Fig. 55 Germany clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Key country dynamics
  • Fig. 57 France clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 Italy clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Key country dynamics
  • Fig. 61 Spain clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Key country dynamics
  • Fig. 63 Denmark clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Key country dynamics
  • Fig. 65 Sweden clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Key country dynamics
  • Fig. 67 Norway clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Asia Pacific clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Key country dynamics
  • Fig. 70 China clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Key country dynamics
  • Fig. 72 India clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Key country dynamics
  • Fig. 74 Japan clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 Key country dynamics
  • Fig. 76 Australia clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 Key country dynamics
  • Fig. 78 South Korea clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 Thailand clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 81 Latin America clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 Key country dynamics
  • Fig. 83 Brazil clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 84 Key country dynamics
  • Fig. 85 Mexico clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 86 Key country dynamics
  • Fig. 87 Argentina clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 88 Key country dynamics
  • Fig. 89 Colombia clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 90 MEA clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 91 Key country dynamics
  • Fig. 92 South Africa clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 93 Fig. Key country dynamics
  • Fig. 94 Saudi Arabia clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 95 Key country dynamics
  • Fig. 96 UAE clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 97 Key country dynamics
  • Fig. 98 Kuwait clinical trial biorepository & archiving solutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 99 Key company categorization
  • Fig. 100 Service heat map analysis
  • Fig. 101 Strategic framework